Investment
Features
FeesSafety
Academy
More
Pluang+

Compare New Era Energy & Digital Inc. Common Stock (NUAI) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

New Era Energy & Digital Inc. Common StockTrade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

New Era Energy & Digital Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? New Era Energy & Digital Inc. Common Stock trades at $4.7 (market cap $583.45M), while Roivant Sciences Ltd. Common Shares trades at $35.12 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 42.4× New Era Energy & Digital Inc. Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, New Era Energy & Digital Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold New Era Energy & Digital Inc. Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.

NUAIROIV
Market Cap
$583.45M$24.72B
Volume
17,217,4126,279,442
Sector
TechnologyHealth
52-Week High
$8.06$41.81
52-Week Low
$2.35$16.04
Typical Hold Time
0 Days1 Days
Enterprise Value
$528.80M$20.99B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUAI
100% Buy0% Sell
Avg holding period · 0 Days
ROIV

No sentiment data available yet.

Top news

Latest headlines on both assets

About New Era Energy & Digital Inc. Common Stock

New Era Energy & Digital develops large-scale data centers in energy-rich U.S. markets for AI training and inference workloads. Its Texas Critical Data Centers project in the Permian Basin combines modular deployment with flexible power solutions.

Read more on NUAI →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →